CDC: Vaccine found safe, effective against mpox during outbreak
![Black person receiving vaccination in arm](/sites/default/files/styles/900x400/public/2022-08/ifdhe-carousel-covid-vaccine-900x400.jpg?itok=y5yO0Cvh)
In a study of men under age 50 who were eligible to receive the JYNNEOS vaccine to prevent monkeypox (mpox) during the U.S. outbreak this year, unvaccinated men were 10 times more likely to get the virus than men who received the two-dose vaccine, and seven times more likely to get it than men who received only one vaccine dose, the Centers for Disease Control and Prevention reported yesterday. A second study found no major vaccine safety concerns after nearly 1 million JYNNEOS doses were administered in the U.S. during the outbreak, CDC said. The agency recommends the vaccine for people at risk for the virus, and encourages everyone eligible to receive the complete two-dose series for best protection.
Related News Articles
Headline
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.…
Headline
As summer Pride parades and other large gatherings approach, Americans at high risk for mpox (monkeypox) exposure should ensure they are fully vaccinated with…
Headline
The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in…
Headline
The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as…
Headline
The World Health Organization today recommended a new name for monkeypox that is intended to mitigate a rise in related racist and stigmatizing language…
Headline
The Department of Health and Human Services today renewed the nation’s monkeypox public health emergency declaration for another 90 days. When the PHE was…